Last reviewed · How we verify
Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years of age. This study is being conducted to look at the safety of EFV, blood levels of EFV, genetic factors that may affect blood levels of EFV, and how easy it is for infants and young children to take and tolerate EFV. This information will help recommend the best doses of EFV for children younger than 3 years of age.
Details
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 67 |
| Start date | Wed Feb 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Feb 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- HIV Infections
- Tuberculosis
Interventions
- Efavirenz (EFV)
- Rifampin-containing anti-TB therapy
Countries
Zimbabwe, South Africa, Uganda, India